Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 18, 2015

Primary Completion Date

April 30, 2020

Study Completion Date

December 31, 2020

Conditions
Liver FailureMajor Hepatectomy
Interventions
DEVICE

MID-AVR

"Phase A (4 patients): After laparotomy and dissection of hepatic pedicle, feasibility of MID-AVR positioning around the portal vein by hepato-biliary surgeon and visual evaluation of potential spatial conflict with hepatic artery and choledochal. Mid-AVR is removed at the end of surgery. Each procedure will be filmed.~Phase B (12 patients): Mid-AVR is maintained at the end of surgery, and during 48 hours to evaluate the persistence of an hepatopetal portal flow without portal vein thrombosis upstream MID-AVR during the 48 hours after the liver surgery at bi-daily ultrasonography."

Trial Locations (1)

94

RECRUITING

AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire, Villejuif

All Listed Sponsors
collaborator

Medical Innovation Developpement (MID)

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER